| Price Range 12mo avg: | $793K – $7.3M |
|---|---|
| $/sf 12mo avg: | $263.80 |
| CAP Rate 12mo avg: | 8.02% |
| NOI average: | $246,946 |
| Lease Terms: | 20yrs NN |
| Building Size avg: | 12,400 SF |
| Lot Size avg: | 1.80+/- acres |
| S&P Credit Rating: | B |
|---|---|
| Moody’s Credit Rating: | B2 |
| Annual Revenue 2014: | $25.5B |
| Annual Revenue 2013: | $25.4B |
| Revenue Growth: | ↑ 0.5% from 2013 |
| Net Income | $249.4M |
| Units (Mar. 2014) | 4,587 |
| Average Units Volume: | $5.8M |
Yahoo! Finance: RAD News Latest Financial News for RAD
-
Rite Aid Corporation -- Moody's changes Rite Aid's outlook to stable; affirms Caa1 CFR
on October 16, 2020 at 10:12 pm
Moody's Investors Service, ("Moody's") today changed the outlook for Rite Aid Corporation ("Rite Aid") to stable from negative. All other ratings including the company's Caa1 corporate family rating and its Caa1-PD probability of default rating are affirmed and there is no change in the company's SGL-3 speculative grade liquidity rating. "Rite Aid has proactively addressed a large portion of its 2023 maturities which is a credit positive but operational and competitive challenges remain", Moody's Vice President Mickey Chadha stated. […]
-
Rite Aid to Release Second Quarter Results on September 24
on September 8, 2020 at 12:30 pm
Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2021 Second Quarter, which ended Aug. 29, 2020, on Thursday, Sept. 24, 2020. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://www.riteaid.com/corporate/investor-relations/presentations. […]
-
Rite Aid Names Bari Harlam to Board of Directors
on August 27, 2020 at 12:30 pm
Rite Aid (NYSE: RAD) has appointed Bari Harlam to its board of directors effective Sept. 1, 2020. A successful C-suite leader, marketer, educator and author, Harlam brings deep marketing expertise and a powerful understanding of the customer of the future to the company’s board. Rite Aid has continued to bolster its leadership at all levels in support of the organization’s RxEvolution strategy, which aims to position Rite Aid as a leading destination for whole being health, where traditional and alternative therapies align. […]
-
Rite Aid Prepares for Flu Season: Flu Shots Now Available at All Rite Aid Locations
on August 18, 2020 at 2:00 pm
Rite Aid (NYSE: RAD) announced today that seasonal flu shots are now available at all Rite Aid locations. Amidst the COVID-19 pandemic, the drug store chain encourages all age groups to get flu shots as soon as possible to help maintain strong immune systems, keep communities thriving and play a role in minimizing the number of flu hospitalizations this year. […]
-
Two Key Leaders Join Rite Aid to Accelerate RxEvolution
on August 11, 2020 at 2:00 pm
Rite Aid (NYSE: RAD) has deepened its bench of health industry leaders with the appointment of two new executives: Roxanne Schwans has joined the company to lead market access and pharmacy purchasing, and Chris Bohrer has joined to build out Rite Aid’s health plan solutions business and strategic initiatives. Rite Aid continues to align key personnel with the company’s revitalized strategy, which puts the pharmacist at the center of a holistic approach to healthcare addressing mind, body and spirit. Both hires further strengthen Rite Aid’s position to improve the overall health and wellbeing of its consumers, while amplifying the impact of the health plans and providers that serve them. In addition, both Schwans and Bohrer actively engage with Rite Aid’s pharmacy services unit Elixir, to further support the value its PBM business brings to health plans and payors. […]
NYSE: RAD
